Core Insights - Analysts project Check Point Software (CHKP) will report quarterly earnings of $2.36 per share, reflecting an 8.8% year-over-year increase [1] - Revenue is expected to reach $660.83 million, marking a 5.3% increase from the same quarter last year [1] Earnings Estimates - The consensus EPS estimate has remained unchanged over the past 30 days, indicating analysts have not revised their projections [2] - Changes in earnings estimates are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate revisions and short-term stock performance [3] Revenue Projections - Total revenues from products and security subscriptions are projected to be $423.58 million, representing an 8.7% year-over-year increase [5] - Revenues from software updates and maintenance are estimated at $237.06 million, indicating a slight decrease of 0.2% from the previous year [5] - Revenues from products and licenses are expected to be $123.35 million, reflecting a 4.5% increase year-over-year [6] - Security subscriptions revenue is projected at $300.62 million, suggesting a 10.6% year-over-year increase [6] Stock Performance - Check Point shares have decreased by 1.3% over the past month, contrasting with a 3.6% increase in the Zacks S&P 500 composite [6] - The company holds a Zacks Rank of 3 (Hold), indicating it is expected to perform in line with the overall market in the near future [6]

Core Viewpoint - Ameren (AEE) is expected to report quarterly earnings of $1.00 per share, a 3.1% increase year-over-year, with revenues projected at $1.88 billion, reflecting a 10.8% year-over-year growth [1]. Earnings Estimates - The consensus EPS estimate has been revised upward by 1.2% in the last 30 days, indicating analysts' reassessment of their initial estimates [2]. - Revisions to earnings estimates are crucial indicators for predicting investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term stock price performance [3]. Revenue Estimates - Analysts predict 'External revenues - Ameren Illinois Electric Distribution' to reach $540.77 million, a 6.2% year-over-year increase [5]. - 'External revenues - Ameren Illinois Natural Gas' is estimated at $149.99 million, reflecting a 1.3% increase from the previous year [5]. - 'Electric Revenues - Ameren Missouri - Total' is forecasted at $951.36 million, indicating a 10.1% year-over-year change [6]. - 'Electric Revenues - Ameren Illinois Electric Distribution - Total' is expected to be $542.00 million, showing a 6.5% increase from the prior year [6]. - 'Operating Revenues - Natural gas' is estimated at $175.20 million, a 1.9% increase year-over-year [7]. - 'Gas Revenues - Ameren Illinois Natural Gas' is projected to reach $152.05 million, indicating a 2.7% year-over-year change [7]. - 'Operating Revenues - Electric' is expected to be $1.62 billion, reflecting a 6.7% increase from the previous year [8]. - 'Electric Revenues - Ameren Transmission - Total' is forecasted at $206.52 million, indicating an 8.1% year-over-year change [8]. Sales and Income Estimates - 'Electric Sales - Ameren Total' is expected to reach 17,177 gigawatt hours, compared to 17,110 gigawatt hours reported in the same quarter last year [9]. - 'Operating Income - Ameren Missouri' is projected to be $191.89 million, up from $144.00 million reported in the same quarter of the previous year [9]. Stock Performance - Over the past month, Ameren shares have recorded a return of +2.4%, while the Zacks S&P 500 composite has changed by +3.6% [9]. - Ameren holds a Zacks Rank 3 (Hold), suggesting its performance is likely to align with the overall market in the upcoming period [9].

Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short- term price performance of a stock. While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during t ...

Core Viewpoint - Analysts forecast Regeneron (REGN) will report quarterly earnings of $8.03 per share, reflecting a year-over-year decline of 30.5%, with anticipated revenues of $3.34 billion, a decrease of 5.7% compared to the previous year [1]. Earnings Estimates - The consensus EPS estimate has been revised downward by 6.5% over the past 30 days, indicating a collective reassessment by analysts [2]. - Revisions to earnings estimates are crucial indicators for predicting investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term stock price performance [3]. Revenue Forecasts - Analysts predict 'Revenues- Other Revenue' at $125.38 million, a year-over-year increase of 20% [5]. - 'Revenues- Net product sales' are expected to reach $1.46 billion, reflecting a decline of 23.9% year-over-year [5]. - 'Total Bayer collaboration revenue' is projected at $388.54 million, indicating a year-over-year increase of 3.6% [5]. - The consensus estimate for 'Revenues- Collaboration' stands at $1.73 billion, a year-over-year increase of 13.7% [6]. - 'Revenues- Eylea (Aflibercept)- US' are expected to be $1.03 billion, down 33% from the prior year [6]. - 'Revenues- Praluent (alirocumab)- US' are forecasted at $54.57 million, a decrease of 2.7% year-over-year [6]. Product-Specific Revenue Insights - 'Revenues- Libtayo- US' are estimated to reach $234.04 million, reflecting a year-over-year increase of 28.3% [7]. - 'Revenues- Evkeeza- US' are expected at $36.84 million, indicating an 18.8% year-over-year increase [7]. - 'Revenues- Dupixent (dupilumab)- ROW' are projected at $1.16 billion, a year-over-year increase of 22.7% [8]. - 'Revenues- Dupixent (dupilumab)- US' are expected to reach $3.05 billion, reflecting a year-over-year increase of 16.7% [8]. - 'Revenues- Kevzara (sarilumab)- ROW' are estimated at $47.83 million, indicating a year-over-year increase of 7.2% [9]. Market Performance - Over the past month, shares of Regeneron have returned +6.4%, outperforming the Zacks S&P 500 composite's +3.6% change [9].

Analysts forecast 'Net revenues- Investment advisory fees' to reach $1.56 billion. The estimate indicates a change of -1.8% from the prior-year quarter. The consensus estimate for 'Net revenues- Investment Advisory Fees- Alternatives' stands at $79.68 million. The estimate indicates a year-over-year change of -13.1%. Wall Street analysts forecast that T. Rowe Price (TROW) will report quarterly earnings of $2.11 per share in its upcoming release, pointing to a year-over-year decline of 6.6%. It is anticipate ...

Core Viewpoint - Analysts forecast that CBOE Global (CBOE) will report quarterly earnings of $2.42 per share, reflecting a year-over-year increase of 12.6%, with anticipated revenues of $572.24 million, an increase of 11.4% compared to the previous year [1]. Earnings Estimates - The consensus EPS estimate for the quarter has been revised 0.7% higher over the last 30 days, indicating a collective reevaluation by analysts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock performance [3]. Revenue Projections - Analysts estimate 'Revenues- Net transaction and clearing fees' at $423.80 million, indicating a year-over-year change of +13.3% [5]. - 'Revenues- Futures- Transaction and clearing fees' are projected to reach $28.59 million, reflecting a change of +1.7% from the prior-year quarter [5]. - The consensus estimate for 'Revenues- Global FX- Transaction and Clearing Fees' stands at $19.39 million, with a year-over-year change of +13.4% [6]. - 'Revenues- Options- Transaction and clearing fees' are estimated at $436.32 million, suggesting a change of +13.1% year over year [6]. - 'Revenues- Options- Market data fees' are forecasted to reach $34.73 million, indicating a change of +12% year over year [6]. - 'Revenues- Options- Access and capacity fees' are expected to be $43.68 million, reflecting a change of +5% from the prior-year quarter [7]. Volume Metrics - Analysts predict 'Average Daily Volume by Product - Options - Multi-listed options' to reach 12.58 million, compared to 10.37 million in the previous year [7]. - 'Average Daily Volume by Product - Options - Index options' is expected to reach 4.62 million, up from 4.02 million year-over-year [8]. - 'Average Daily Volume by Product - Futures' is projected at 238.83 thousand, down from 253.60 thousand in the same quarter last year [8]. - 'Average Daily Volume by Product - Options' is estimated to reach 17.20 million, compared to 14.38 million in the previous year [9]. - The average prediction for 'Average Daily Notional Volume by Product - Global FX' is 55.22 billion, up from 47.70 billion in the same quarter last year [9]. - 'Average Daily Volume - Total Industry Options' is expected to reach 53.21 million, compared to 46.13 million in the same quarter last year [10]. Stock Performance - Over the past month, CBOE shares have recorded returns of +3.6%, aligning with the Zacks S&P 500 composite's +3.6% change, indicating a performance that is likely to align with the overall market [11].

Core Insights - Wall Street analysts forecast Tyler Technologies (TYL) will report quarterly earnings of $2.78 per share, reflecting a year-over-year increase of 15.8% [1] - Anticipated revenues are projected to be $586.23 million, showing an increase of 8.4% compared to the same quarter last year [1] Earnings Estimates - Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter, indicating stability in analysts' forecasts [2] - Changes in earnings estimates are crucial for predicting investor reactions to the stock, with empirical studies showing a strong relationship between earnings estimate revisions and short-term price performance [3] Revenue Projections - Analysts estimate 'Revenue- Subscriptions' will reach $391.37 million, a change of +17.3% from the year-ago quarter [5] - 'Revenue- Professional services' is expected to be $68.77 million, indicating a decrease of -4.4% year over year [5] - 'Revenue- Recurring' is forecasted to be $501.75 million, reflecting an increase of +11.8% from the prior-year quarter [5] Additional Revenue Insights - 'Revenue- Hardware and other' is projected at $11.09 million, suggesting a decline of -24.7% year over year [6] - 'Revenue- Software licenses and royalties' is expected to be $4.67 million, indicating a decrease of -12.5% year over year [6] - 'Revenue- Maintenance' is forecasted at $110.33 million, reflecting a change of -4.3% from the prior-year quarter [6] Profit Estimates - 'Revenue- Non-Recurring' is estimated at $84.48 million, suggesting a decline of -8.2% year over year [7] - 'Gross profit- Hardware and other' is projected to reach $3.61 million, down from $4.00 million in the previous year [7] - 'Gross profit- Software licenses and royalties' is estimated at $3.74 million, slightly lower than the $3.77 million reported in the same quarter last year [8] Stock Performance - Tyler Technologies shares have decreased by -6.1% in the past month, contrasting with the Zacks S&P 500 composite's +3.6% performance [8] - The company holds a Zacks Rank 3 (Hold), indicating it is expected to closely follow overall market performance in the near term [8]

Core Viewpoint - Analysts expect Exxon Mobil (XOM) to report quarterly earnings of $1.49 per share, reflecting a year-over-year decline of 30.4%, with revenues projected at $82.82 billion, down 11% from the previous year [1] Earnings Estimates - The consensus EPS estimate has been revised 10.7% higher in the last 30 days, indicating a collective reevaluation by analysts [1][2] Revenue Projections - Analysts estimate 'Revenues- Other income' to be $618.89 million, a decrease of 53.5% year over year [4] - 'Revenues- Sales and other operating revenue' is projected at $80.11 billion, down 11% year over year [4] - 'Revenues- Income from equity affiliates' is expected to reach $1.56 billion, indicating a decline of 10.4% [4] Segment Analysis - 'Revenues- Sales and other operating revenue- Energy Products' is forecasted at $61.18 billion, down 11.9% from the year-ago quarter [5] - 'Revenues- Sales and other operating revenue- Energy Products- United States' is estimated at $24.24 billion, reflecting an 8.2% decline [5] - 'Revenues- Sales and other operating revenue- Energy Products- Non-U.S.' is projected at $36.94 billion, down 14.1% [6] - 'Revenues- Sales and other operating revenue- Chemical Products- United States' is expected to be $1.97 billion, a decrease of 11.2% [6] Upstream and Production Metrics - 'Revenues- Sales and other operating revenue- Upstream- United States' is estimated at $6.04 billion, down 10.3% year over year [7] - Oil-equivalent production per day is projected to reach 4,547 thousand barrels, compared to 4,358 thousand barrels in the same quarter last year [7] - Natural gas production available for sale per day in Europe is expected to be 285 thousand cubic feet, down from 331 thousand cubic feet reported last year [8] - For Africa, natural gas production is projected at 147 thousand cubic feet per day, down from 167 thousand cubic feet last year [9] - In Asia, natural gas production is expected to be 3,328 thousand cubic feet per day, down from 3,486 thousand cubic feet reported last year [9] Stock Performance - Exxon's shares have changed by +3.4% in the past month, compared to a +3.6% move of the Zacks S&P 500 composite [10]

Group 1 - Mettler-Toledo (MTD) is expected to report quarterly earnings of $9.58 per share, a decline of 0.7% year-over-year, with revenues forecasted at $957.64 million, reflecting a 1.1% increase [1] - The consensus EPS estimate for the quarter has remained unchanged over the past 30 days, indicating analysts' reassessment of their initial projections [1] - Analysts project 'Net Sales- Products' to be $726.47 million, showing a year-over-year increase of 2% [4] Group 2 - 'Net Sales- Service (Point in Time+Over Time)' is estimated to reach $229.94 million, indicating a decline of 1.9% year-over-year [4] - 'Net Sales- Retail' is expected to be $47.83 million, reflecting a decrease of 2.9% compared to the previous year [4] - 'Net Sales- Industrial' is projected at $384.01 million, representing a year-over-year increase of 2.6% [5] Group 3 - 'Net Sales- Laboratory' is anticipated to be $529.10 million, indicating a 1.1% increase from the prior-year quarter [5] - Mettler-Toledo shares have recorded a return of 7.4% over the past month, outperforming the Zacks S&P 500 composite's 3.6% change [5] - Based on its Zacks Rank 3 (Hold), Mettler-Toledo is expected to perform in line with the overall market in the upcoming period [5]

Core Viewpoint - Analysts project that W.W. Grainger (GWW) will report quarterly earnings of $10.00 per share, reflecting a 2.5% year-over-year increase, with revenues expected to reach $4.52 billion, a 4.8% increase from the same quarter last year [1]. Earnings Estimates - Over the last 30 days, the consensus EPS estimate has been revised downward by 0.3%, indicating a collective reassessment by covering analysts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate revisions and short-term stock price performance [3]. Key Metrics Projections - Analysts forecast 'Net Sales- High-Touch Solutions N.A.' to reach $3.55 billion, a 2.7% increase from the prior year [5]. - The estimate for 'Net Sales- Endless Assortment' is projected at $887.37 million, indicating a 14.4% increase from the previous year [5]. - 'Net Sales- Other' is expected to be $81.42 million, reflecting a 4.4% increase from the prior year [5]. - The consensus estimate for 'Total Reported Growth' is 4.8%, compared to 3.1% from the previous year [6]. - Analysts predict 'Operating earnings (losses)- High-Touch Solutions N.A.' at $609.17 million, up from $591.00 million year-over-year [6]. - For 'Operating earnings (losses)- Endless Assortment', the estimate is $76.73 million, compared to $61.00 million from the previous year [6]. Stock Performance - Over the past month, W.W. Grainger shares have returned +0.8%, while the Zacks S&P 500 composite has changed by +3.6% [7]. - Based on its Zacks Rank 3 (Hold), GWW is expected to perform in line with the overall market in the upcoming period [7].